VSee Health, Inc. executed a Strata Purchase Agreement with Clearthink Capital Partners, LLC on September 2, 2026, committing to purchase up to $5.0 million of the company's common stock at its direction over approximately 36 months following SEC effectiveness of a resale registration statement. The purchase price is set at 85% of the lowest daily closing price during the ten trading days preceding each purchase date. As consideration for this commitment, VSee Health issued 40,000 shares of common stock to Clearthink upon execution. Proceeds will be used for working capital and general corporate purposes. The company operates in the healthcare technology sector.
